SAMG vs. RIGL
SAMG (Silvercrest Asset Management Group Inc.) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. SAMG operates in Asset Management (Financial Services), while RIGL operates in Biotechnology (Healthcare). Over the past 10 years, SAMG returned 3.48%/yr vs 1.92%/yr for RIGL. At a 0.21 correlation, their price movements are largely independent.
Performance
SAMG vs. RIGL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SAMG achieves a -25.31% return, which is significantly higher than RIGL's -29.37% return. Over the past 10 years, SAMG has outperformed RIGL with an annualized return of 3.48%, while RIGL has yielded a comparatively lower 1.92% annualized return.
SAMG
- 1D
- 0.72%
- 1M
- -16.69%
- YTD
- -25.31%
- 6M
- -23.48%
- 1Y
- -19.51%
- 3Y*
- -13.64%
- 5Y*
- -3.77%
- 10Y*
- 3.48%
RIGL
- 1D
- -0.17%
- 1M
- 7.69%
- YTD
- -29.37%
- 6M
- -36.15%
- 1Y
- 47.27%
- 3Y*
- 28.97%
- 5Y*
- -5.34%
- 10Y*
- 1.92%
SAMG vs. RIGL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SAMG Silvercrest Asset Management Group Inc. | -25.31% | -13.00% | 13.34% | -5.65% | 13.58% | 28.82% | 16.48% | -0.55% | -14.49% | 26.39% |
RIGL Rigel Pharmaceuticals, Inc. | -29.37% | 154.64% | 16.00% | -3.33% | -43.40% | -24.29% | 63.55% | -6.96% | -40.72% | 63.03% |
Correlation
The correlation between SAMG and RIGL is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Jun 28, 2013 | 0.21 |
Fundamentals
SAMG:
$86.41M
RIGL:
$595.50M
SAMG:
$0.35
RIGL:
$19.21
SAMG:
31.53
RIGL:
1.57
SAMG:
0.74
RIGL:
1.91
SAMG:
1.84
RIGL:
1.49
SAMG:
$125.34M
RIGL:
$299.77M
SAMG:
$39.13M
RIGL:
$279.95M
SAMG:
$8.40M
RIGL:
$125.80M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SAMG vs. RIGL — Risk / Return Rank
SAMG
RIGL
SAMG vs. RIGL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Silvercrest Asset Management Group Inc. (SAMG) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SAMG | RIGL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.40 | ||
| Sortino ratioReturn per unit of downside risk | -2.40 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 1.19 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 0.95 | -1.56 |
| Martin ratioReturn relative to average drawdown | -1.49 | 1.69 | -3.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| SAMG | RIGL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.72 | 0.68 | -1.40 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.11 | -0.06 | -0.05 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.09 | 0.02 | +0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.09 | -0.13 | +0.22 |
Drawdowns
SAMG vs. RIGL - Drawdown Comparison
The maximum SAMG drawdown since its inception was -54.78%, smaller than the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for SAMG and RIGL.
Loading charts...
Drawdown Indicators
| SAMG | RIGL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.78% | -99.37% | +44.59% |
Max Drawdown (1Y)Largest decline over 1 year | -31.92% | -50.08% | +18.16% |
Max Drawdown (3Y)Largest decline over 3 years | -43.26% | -57.75% | +14.49% |
Max Drawdown (5Y)Largest decline over 5 years | -43.26% | -85.24% | +41.98% |
Max Drawdown (10Y)Largest decline over 10 years | -54.78% | -86.40% | +31.62% |
Current DrawdownCurrent decline from peak | -42.85% | -97.17% | +54.32% |
Average DrawdownAverage peak-to-trough decline | -18.33% | -90.91% | +72.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.11% | 28.10% | -14.99% |
Volatility
SAMG vs. RIGL - Volatility Comparison
The current volatility for Silvercrest Asset Management Group Inc. (SAMG) is 10.65%, while Rigel Pharmaceuticals, Inc. (RIGL) has a volatility of 19.23%. This indicates that SAMG experiences smaller price fluctuations and is considered to be less risky than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SAMG | RIGL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.65% | 19.23% | -8.58% |
Volatility (6M)Calculated over the trailing 6-month period | 20.29% | 38.92% | -18.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.34% | 69.85% | -42.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.21% | 85.50% | -52.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 40.81% | 82.81% | -42.00% |
Dividends
SAMG vs. RIGL - Dividend Comparison
SAMG's dividend yield for the trailing twelve months is around 7.42%, while RIGL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RIGL Rigel Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SAMG Silvercrest Asset Management Group Inc. | 7.42% | 5.40% | 4.24% | 4.35% | 3.73% | 3.84% | 4.61% | 4.77% | 4.23% | 2.99% | 3.65% | 4.04% |
Financials
SAMG vs. RIGL - Financials Comparison
This section allows you to compare key financial metrics between Silvercrest Asset Management Group Inc. and Rigel Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SAMG vs. RIGL - Profitability Comparison
SAMG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Silvercrest Asset Management Group Inc. reported a gross profit of 10.26M and revenue of 31.41M. Therefore, the gross margin over that period was 32.7%.
RIGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a gross profit of 54.21M and revenue of 58.82M. Therefore, the gross margin over that period was 92.2%.
SAMG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Silvercrest Asset Management Group Inc. reported an operating income of 1.26M and revenue of 31.41M, resulting in an operating margin of 4.0%.
RIGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported an operating income of 11.89M and revenue of 58.82M, resulting in an operating margin of 20.2%.
SAMG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Silvercrest Asset Management Group Inc. reported a net income of 533.00K and revenue of 31.41M, resulting in a net margin of 1.7%.
RIGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Rigel Pharmaceuticals, Inc. reported a net income of 8.65M and revenue of 58.82M, resulting in a net margin of 14.7%.
Frequently Asked Questions
SAMG and RIGL have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RIGL has higher volatility (19.23%) compared to SAMG (10.65%). In terms of maximum drawdown, SAMG dropped -54.78% vs RIGL's -99.37%.
RIGL currently has the higher Sharpe Ratio (0.68 vs -0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SAMG and RIGL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer